baber/WOPTO huggingface dataset:
Patent FI-873873-A0 (FI)
Inventor: LINDEN ANTTI
IPC: C03B37/10
Filed: 1987-09-08
Abstract: PCT No. PCT/FI88/00130 Sec. 371 Date Apr. 14, 1989 Sec. 102(e) Date Apr. 14, 1989 PCT Filed Aug. 15, 1988 PCT Pub. No. WO89/02420 PCT Pub. Date Mar. 23, 1989.A method of and an apparatus for cooling an optical fibre drawn from a heated glass blank by passing the fibre (3) through a cooling pipe (9) in which a cooling gas (A) flows in the axial direction of the fibre around it. In order to reduce the consumption of cooling gas, the cooling gas is caused to flow turbulently (B) around the fibre by a throttle point (20) formed by a partition wall (19) in the cooling pipe, so that a laminar flow of cooling gas around the fibre is prevented and the transfer of heat between the cooling gas and the fibre is improved.
Patent FI-905145-A0 (FI)
Inventor: CUMMINS THOMAS JOSEPH
IPC: C12Q1/68
Filed: 1990-10-18
Abstract: This invention provides a rapid and highly effective method for extracting nucleic acids from cells or virions without the use of proteolytic enzymes. Extraction is accomplished within a few minutes using a lysing composition comprising a buffer, a source of a DNA polymerase cofactor, a stabilizer and at least one nonionic surfactant which will release nucleic acids from cytoplasmic and nuclear membranes of cells or from virions. The resulting mixture is heated to boiling for up to fifteen minutes, and the nucleic acids are recovered for amplification using polymerase chain reaction. No proteolytic enzyme is used in the extraction process.
Patent FI-921020-A0 (FI)
Inventor: CARMIEN JOSEPH ALLEN
IPC: B25G3/34
Filed: 1992-03-09
Abstract: A tool handle includes a tapered shaft retainer which is dimensioned for insertion into the eyehole of a tool head, a high strength handle shaft bonded within the shaft retainer, and a grip which ensheathes the handle shaft. The shaft retainer includes an outer surface portion generally corresponding to a portion of the eyehole, an upper enlarged portion which is incapable of passing through the eyehole, and a slightly tapered inner cavity. The shaft retainer is inserted into the eyehole from the top end thereof, a measured adhesive is placed into the inner cavity, and then the handle shaft is pressed therein through a lower end of the eyehole. In order to improve the bond between the shaft retainer and the upper end of the handle shaft, keyways are provided on the upper end of the shaft and within the inner cavity of the shaft retainer. The grip may be molded directly onto the handle shaft prior to assembly of the shaft retainer to the handle shaft, or the grip may be slidably received onto the handle shaft afterwards and then attached thereto. In such a case, in one preferred method of assembly, an adhesive compound is placed within the grip prior to its being slid onto the handle shaft. In another preferred method of assembly, a mechanical attachment is utilized between the girp and the handle shaft.
Patent FI-922458-A0 (FI)
Inventor: POURCHOT THIERRY
IPC: G07C3/00
Filed: 1992-05-27
Abstract: The fouling of the compressor (2) of a gas turbine (4) is monitored with the aid of a processor (32) which comprises a normalisation algorithm (36). The latter is supplied by performance parameter sensors (24, 26, 28) measuring the performance characteristics of the compressor and by sensors for influencing parameters (10, ... 22) which measure quantities imposed from outside this compressor. It supplies an internal parameter representing the fouling of this compressor to a terminal (40) via a Kalman filter (38). The invention applies especially to the maintenance of a gas turbine. <IMAGE>
Patent FI-924305-A0 (FI)
Inventor: GEHLERT DONALD RICHARD
IPC: A61P25/18
Filed: 1992-09-25
Abstract: This invention provides N-alkyl-3-phenyl-3-(2-substituted phenoxy)propylamines which are useful to treat neurological disorders associated with norepinephrine imbalance.
Patent FI-934209-A0 (FI)
Inventor: HARTZELL ROLF
IPC: B65B1/02
Filed: 1993-09-24
Abstract: Apparatus for filling a plurality of capsules with a selected medicine, the capsules each having a closed lower end and an open top end and being mounted in the apparatus for filling the medicine into the capsules through the open top end, the apparatus comprising a dosing mechanism which separately measures a selected quantity of the medicine for input into each capsule; a capsule filling mechanism comprising a plurality of funnels each having an axis, the funnels each receiving a measured quantity of medicine and funneling the received medicine to an open delivery end of the funnels; the capsules being mounted such that the open top ends of the capsules are disposed at the open delivery ends of the funnels for receipt of the measured quantities of medicine; the filling mechanism further comprising a plurality of spiral spring mechanisms, the spiral spring mechanisms being insertable through the open top ends and removable from the capsules, the spiral spring mechanisms further being rotatable simultaneously with insertion into the capsules for filling the capsules with the measured quantities of medicine.
Patent FI-941389-A0 (FI)
Inventor: MILOHANIC SLOBODAN
IPC: A23G3/20
Filed: 1994-03-25
Abstract: An applicator (10) for dosing a layer of filling (33) onto a substrate travelling on a continuously moving conveyor comprising a conveyor (11), a nozzle (28) having a mould opening (29) in its lower surface and provided with a means for supplying a filling (33) into the mould opening (29), means for reciprocating the nozzle (28) vertically above the conveyor (11) and horizontally in the direction of travel of the conveyor (11) so that in one cycle,   a) the nozzle (28) descends so that the border of the mould opening (29) contacts a substrate (12) travelling on the conveyor (11),   b) the filling (33) is fed into the mould opening (29), c) the nozzle (28) advances downstream at substantially the same speed as the conveyor (11) with the filling (33) in the mould opening (29) lying on the substrate (12), d) the nozzle (28) ascends leaving the moulded filling (33) forming a layer on the substrate (12), and   e) the nozzle (28) retracts upstream to its original position.   <IMAGE>
Patent FI-942115-A0 (FI)
Inventor: OPPONG DAVID
IPC: A01N47/12
Filed: 1994-05-06
Abstract: Synergistic combinations of iodopropargyl compounds and 1,2-benzisothiazolin-3-one for use in controlling the growth of at least one microorganism, such as fungi and bacteria in aqueous fluids, such as metalworking fluids.
Patent FI-944802-A0 (FI)
Inventor: BERNSTEIN PETER ROBERT
IPC: C07K5/06
Filed: 1994-10-12
Abstract: The present invention relates to certain novel heterocyclic compounds which are 1-pyridylacetamide compounds of formula (I), set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic compounds, processes for preparing the heterocyclic compounds, pharmaceutical compositions containing such heterocyclic compounds and methods for their use.
Patent FI-945486-A0 (FI)
Inventor: KUEBER FRANK
IPC: C08F10/00
Filed: 1994-11-22
Abstract: The present invention relates to a polynuclear metallocene compound of the formula I <IMAGE> a process for its preparation and its use as a catalyst for olefin polymerisation.
Patent FI-982520-A0 (FI)
Inventor: WEAWER JR LINSAY A
IPC: H04W36/14
Filed: 1998-11-20
Abstract: The cellular communication system includes a number of base stations through which a mobile unit communicates. The mobile unit maintains a list of active base stations with which it can communicate. One of the active stations is in communication with the mobile and uses this communication to measure the round-trip-delay between mobile and station. This delay is compared with a threshold and if this is exceeded, and the base station is a boundary station, then a hard hand-off is executed. The mobile can also monitor candidate base stations and if a triggering pilot signal is detected a hand-off can be triggered. Preferably the handoff can be between base stations controlled by different mobile switching centres.
Patent IL-59084-A0 (IL)
Title: (piperidinylalkyl)quinazoline derivatives,their preparation and pharmaceutical compositons containing them
IPC: A61K31/517
Filed: 1980-01-07
Abstract: Quinazoline derivatives of the formula 
<CHEM>
 wherein Ra is hydrogen or alkyl and and q is 2 or 3;
 R is hydorgen, hydroxy and alkyl;
 Alk is an alkylene chain having from 1 to 4 carbon atoms and Q is a quinazolinyl radical, the 1-, 2-, 3- or 4-position of which is connected with the alkylene side chain, said quinazolinyl radical bearing in one or both of its 2-and 4-positions a carbonyl or thiocarbonyl group, wherein the benzene ring of said quinazolinyl radical is optionally substituted with 1 to 3 substituents each independently selected from the group consisting of halo, alkyl; alkyloxy, trifluoromethyl, nitro and cyano, and wherein the pyrimidino ring of said quinazolinyl radical may be partly or fully saturated, said pyrimidino ring being optionally substituted with 1 to 3 substituents independently selected from the group consisting of alkyl, aryl and aryl(lower alkyl);
 wherein said aryl as used in the definition of said Ar and of said Q is a member selected from the group consisting of phenyl, substituted phenyl, thienyl and pyridinyl, wherein said substituted phenyl has from 1 to 3 substituents each independently selected from the group consisting of halo, lower alkyl, lower alkyloxy, trifluoromethyl and amino. These derivatives are serotonin antagagonists. Further are described compounds of the formula 
<CHEM>
 (Q, Alk and R have the same meaning as above), R8 and R9 being hydrogen, halogen, alkyl, alkoxy, CF3 and amino, having the same activity.
Patent IL-74371-A0 (IL)
Title: Hydrophilic polymers,process for the preparation thereof and contact lenses made therefrom
IPC: G02C7/04
Filed: 1985-02-19
Abstract: An interpenetrating network polymer comprising of (a) hydrophilic vinyl amide, (b) (5-alkylene-m-dioxanyl) acrylic ester, (c) a first crosslinking agent having an affinity for vinyl amide, and (d) a second crosslinking agent having an affinity for acrylic ester.
Patent IL-90423-A0 (IL)
Title: Interleukin-1 inhibitors
IPC: C12P21/00
Filed: 1989-05-26
Abstract: A substantially purified interleukin-1 inhibitor (IL-li which is active against interleukin-1 alpha or interleukin-1 beta or both of these substances. A recombinant-DNA method for the production of an interleukin-1 inhibitor (IL-li), and an isolated DNA sequence encoding a physiologically functional interleukin-1 inhibitor (IL-li). <IMAGE>
Patent AU-PR155900-A0 (AU)
Title: A mat
IPC: A47G9/06
Filed: 2000-11-20
Abstract: A beach mat is disclosed which comprises a first layer (2) secured to a second layer (3). Each layer (2, 3) is manufactured from a flexible polypropylene mesh material, suitably shade cloth with a shade rating of approximately 70%. The perimeters of each layer (2, 3) are secured together with overlapping tape (4) which is sewn into position. When the mat (1) is placed on sand (5) with the first layer (2) downwards, any sand that passes upwards through the lower surface of the first layer (2) is retained between the first layer (2) and the second layer (3). Any sand that falls on the upper surface of the second layer (4) and passes therethrough is also retained between the first layer (2) and second layer (3). Optionally, a third layer (7) manufactured from polyvinylchloride-coated nylon mesh material can be positioned over the second layer (3) and the perimeters of each layer (2, 3, 6) secured together with overlapping tape (4). The upper surface of the third layer (7) can be screen-printed. Any sand that falls on the upper surface of the third layer (7) passes through that layer and also through the second layer (3) to be retained between the first layer (2) and second layer (3).
Patent AU-PR669001-A0 (AU)
Title: A fluid pressure generating means
IPC: A61M1/12
Filed: 2001-07-30
Abstract: A fluid pressure generating means (10) for a heart assist device having blood pumping means. The pressure generating means (10) includes a housing (11), defining an interior volume (18), and having a substantially rigid first housing portion (12), a substantially rigid second housing portion (14), a flexible third housing portion (16) extending between the first (12) and second (14) housing portions and an inlet/outlet port (15) adapted for fluid communication with the blood pumping means. The pressure generating means (10) also includes a fluid filling the housing and a motor (20) disposed within the housing (11) and connected between the first (12) and second (14) housing portions. Actuation of the motor (20) moves the first (12) and second (14) housing portions relative to one another to generate fluid pressure changes at the inlet/outlet port (15). A related heart assist device and method for the treatment of congestive heart failure, myocardial ischemia and like conditions are also disclosed.
Patent IL-103547-A0 (IL)
Title: Method for lowering latex dilatancy
IPC: C08F2/22
Filed: 1992-10-26
Abstract: Desirable latex characteristics are maintained while eliminating dilatancy by including a sufficient amount of at least one non-polymerizable compound having at least one moiety selected from the group consisting of hydroxyl, amine, thiol, and mixtures thereof in the reaction medium used in the latex emulsion polymerization process.
Patent IL-107459-A0 (IL)
Title: Pressure.sensitive adhesives containing a polyurethane polymer, medical articles containing the same, and methods for the preparation thereof
IPC: A61L15/16
Filed: 1993-11-01
Abstract: Pressure-sensitive adhesives which possess absorptivity and/or permeability properties to remove transepidermal water loss and/or other bodily fluids that come into contact with the adhesive, in combination with a fine balance of cohesion and adhesion properties, can be formulated by controlling the crosslinking of a polyurethane polymer having excess hydroxyl functionality, a glass transition temperature of less than about 0 DEG C, a moisture absorption of at least about 20% of its weight and/or a moisture vapor transmission rate of at least about 300 grams/meter<2>/24 hours measured at 37 DEG C and a 90% relative humidity gradient. Adhesives of these polymers possess a peel adhesion to human skin of between about 0.3 and 4 newtons/cm width of the polymer or adhesive.
Patent IL-143508-A0 (IL)
Title: Phenethyl-5- bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimdine (dabo) derivatives exhibiting spermicidal activity
IPC: A61P15/00
Filed: 1999-12-29
Abstract: Novel phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity as well as anti-viral activity. These novel compounds can be incorporated within contraceptive compositions to provide for spermicidal or sperm-immobilizing activity.
Patent IL-145720-A0 (IL)
Title: Pharmaceutical compositions containing liposome-encapsulated vinca alkaloids
IPC: A61K47/28
Filed: 2000-03-31
Abstract: Liposome-encapsulated vincristine is provided for treating a cancer such as a lymphoma, leukaemia or myeloma and especially non-Hodgkin's Lymphoma or Acute Lymphocytic Leukaemia. The liposomes comprise sphingomyelin and cholesterol in a ratio between 75/25 (mol % sphingomyelin/mol % cholesterol) and 50/50 (mol % sphingomyelin/mol % cholesterol) and vincristine at a concentration of 0.1 to 0.5 mg/ml.
Patent IL-156280-A0 (IL)
Title: Crystalline forms of atorvastatin
IPC: A61P43/00
Filed: 2001-12-19
Abstract: The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.
Patent IL-174842-A0 (IL)
Title: Catheter balloons
IPC: A61L29/06
Filed: 2006-04-06
Abstract: The invention relates to a balloon for medical devices, in particular for catheters used in angioplasty, comprising a polyamide copolymer material characterized in that said polyamide copolymer material is represented by the general formula (I): HO—(PF—OOC—PA-COO—PF—COO—PA)n-COOH in which PA is a polyamide segment and PF is a diol segment comprising dimer diols and/or corresponding OH-terminating diol polyesters and n is a number between 5 and 20.
Patent IL-177893-A0 (IL)
Title: Compositions comprising drospirenone molecularly dispersed
IPC: A61K9/20
Filed: 2006-09-05
Abstract: The present invention relates to liquid pharmaceutical compositions comprising steroidal drugs, such as drospirenone, in molecularly dispersed form. The compositions are adapted for oral administration and preferably to be absorbed from the gastro-intestinal tract. Such compositions are found to have high bioavailability, good chemical stability, and fast in-vitro dissolution release and can be produced under conditions, which do not require costly equipment or safety guards.
Patent IL-179193-A0 (IL)
Title: Method and device for producing an optical link using light flashes
IPC: G01S3/784
Filed: 2006-11-12
Abstract: The method involves implementing a capacitive unit (13) under the form of an arrangement of a number of capacitors (C1-C5). Connection of the capacitors in the arrangement is controlled in a programmed manner so that the resulting capacitance of the capacitive unit increases light pulses (4) generated by electric discharge produced by the capacitive unit and applied to an electronic-flash lamp (3). An independent claim is also included for a device to implement an optical link.
Patent IL-184604-A0 (IL)
Title: A woven material comprising tape-like warp and weft, and an apparatus and method for weaving thereof
Filed: 2007-07-15
Abstract: Novel woven materials, producible by a new weaving method, are described that comprise single or doubled warps and wefts in the form of tapes that are preferably partially stabilized type of fibrous tape. These fibres are caused to occur in a non-linear arrangement during the weaving process. The non-linear fibres can be subsequently straightened by pulling the tape longitudinally. The doubled warps and wefts comprise disconnected tapes. Such separateness of constituent tapes of doubled warp and weft tapes enables them to be slid/slipped relative to each other by pulling longitudinally and laterally without causing any alteration in the woven structure. These novel fabrics solve the problem of uneven fibre distribution and orientation arising from crumples/wrinkles due to compression and stretches due to extension, at the inner and outer sides respectively, when tape-woven fabrics are curved into shapes. Further, by using doubled warps and wefts fabrics with relatively flat/planar sections and thicker/raised wide rib sections can be also created that resemble a bit like a profiled material in its cross-section. Other fabrics like those comprising slant/oblique weft tapes, shaped warp and weft tapes, formed shape within its body are also producible.
Patent IL-186448-A0 (IL)
Title: New modulators of dopamine neurotransmission
IPC: C07D211/30
Filed: 2007-10-07
Abstract: New 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds of Formula 1:   
wherein X N, CH, or C, however X may only be C when the compound comprises a double bond at the dotted line; R 1  is OSO 2 CF 3 , OSO 2 CH 3 , SOR 3 , SO 2 R 3 , COR 3 , NO 2 , or CONHR 3  and when X is CH or C R 1  may also be CF 3 , CN, F, Cl, Br, or I; R 2  is a C 1 -C 4  alkyl, an allyl, CH 2 SCH 3 , CH 2 CH 2 OCH 3 , CH 2 CH 2 CH 2 F, CH 2 CF 3 , 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or -(CH 2 )-R 4 ; R 3  is a C 1 -C 3  alkyl, CF 3 , or N(R 2 ) 2 ; R 4  is a C 3 -C 6  cycloalkyl, 2-tetrahydrofurane or 3-tetra-hydrofurane, as well as pharmaceutically acceptable salts thereof are disclosed. 
Also pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are disclosed.
Patent IL-187083-A0 (IL)
Title: Pretreatment of a biological sample from an autoimmune disease subject
Filed: 2007-11-01
Abstract: The present application describes a method for pretreating a biological sample from an autoimmune disease subject in order to avoid interference, especially where the sample is to be subjected to a cell-based biological activity assay, such as a neutralizing antibody assay.
Patent IL-198555-A0 (IL)
Title: Process for preparing nebivolol
Filed: 2009-05-04
Abstract: The present invention relates to modified nebivolol formate useful in the preparation of highly pure nebivolol.
Patent RO-126076-A0 (RO)
Title: Planar electric heater based on carbonic heating elements
Inventor: ROŞU DORIN
IPC: H05B3/14
Filed: 2010-06-30
Abstract: The invention relates to a heating device. According to the invention, the device consists of a support frame (1) enclosing two heating elements (2) having the external part made of an electrically insulating material consisting of epoxy resins and fibre glass and the internal part made of electrically conductive material consisting of epoxy resins and carbonic fillers and some network connections (3).
Patent IE-910462-A1 (IE)
Title: Triarylmethyl Radicals and the use of inert Carbon Free Radicals in MRI
Inventor: JORGENSEN MIKKEL
IPC: C07B60/00
Filed: 1991-02-12
Abstract: The present invention relates to a method of generating an electron spin resonance enhanced magnetic resonance image of a sample which comprises introducing into the sample a magnetic resonance signal enhancing amount of a free radical and generating an enhanced electron spin resonance image of the sample. The method comprises using as the free radical an inert triarylmethyl free radical, wherein each aryl moiety of said triarylmethyl radical, which may be identical or different, comprises an optionally substituted 6-membered carbocyclic or thienyl ring. The invention also relates to the use of trityls in ESR imaging.
Patent MA-22203-A1 (MA)
Inventor: CAILLE J-C
IPC: A61P9/12
Filed: 1991-07-03
Abstract: The invention relates to the products: <IMAGE>  in which:  R1 = alkyl, alkenyl, alkynyl, alkylthio,  R2B and R3B representing:  - hydrogen, mercapto, formyl, acyl, carboxy, nitro, cyano,  - PO3(R)2, R representing hydrogen, alkyl, aryl, amino or carbamoyl,  - the radicals R4B; - S(O)nR4B; <IMAGE> n = 0 to 2  X = aryl R4B either represents -(CH2)m1-S(O)m2-X-R10, m1 = 0 to 4, m2 = 0 to 2  either m1 is other than 0 and X-R10 represents amino, or whatever the value of m1, X represents single bond or -NH-, -NH-CO-, -NH-CO-NH-,  R10 = alkyl, alkenyl or aryl  or represents hydrogen, alkyl, alkenyl, alkynyl, acyl or amino, - -S-S-R4B', R4B' represents R4B except for amino and alkoxy, and one of R2B and R3B represents -OR4B;  - -S(O)nR4B; <IMAGE> or -S-S-R4B'  m = 0 to 2,  YB = -Y1B-B-Y2B,  Y1B is aryl, B = single bond or -CO-, -O-, -NH-CO-, -CO-NH-, -O-(CH2)p-, p = 1 to 3, Y2B represents hydrogen, cyano, carboxy; in all the isomeric forms and the salts; and to their use as medicaments.